WEDNESDAY, Might 19, 2021 (HealthDay Information) — Researchers have reported the primary case of COVID-19 inflicting harmful, recurring blood clots in a affected person’s arm.
The report affords new perception into how the harm of inflammation attributable to COVID-19 can linger and the way finest to deal with recurring clots, the Rutgers College researchers stated.
There have been stories of decrease extremity blood clots in sufferers after COVID-19, however that is the primary recognized case wherein COVID-19 triggered a blood clot recurrence within the higher arm.
The affected person was an energetic 85-year-old man who had a previous prognosis of higher extremity blood clots, in keeping with the examine printed on-line not too long ago within the journal Viruses.
“The affected person introduced to his main care doctor with complaints of swelling in his left arm and was despatched to the hospital for additional administration the place he was recognized with an higher arm blood clot and an asymptomatic COVID-19 an infection,” stated examine co-leader Payal Parikh, an assistant professor of medication at Rutgers Robert Wooden Johnson Medical College, in New Jersey.
“Whereas his oxygen ranges weren’t diminished, he was hospitalized for the administration of the higher extremity deep vein blood clot. Usually, blood clots are preceded by persistent inflammatory situations exacerbated by immobility, and barely do they happen in sufferers who’re in any other case wholesome and energetic at baseline,” Parikh famous in a Rutgers information launch.
Most deep vein blood clots happen within the legs. Solely about 10% of blood clots happen within the arms, and of these circumstances solely 9% recur, the examine authors famous.
“That is of concern since in 30% of those sufferers, the blood clot can journey to the lung and be presumably deadly,” Parikh stated. “Different disabling problems embody persistent swelling, ache and arm fatigue.”
This case examine exhibits that well being care suppliers ought to contemplate testing for deep vein thrombosis and COVID-19 in sufferers who’ve unexplained swelling, and that individuals who check constructive for COVID-19 ought to search medical consideration if they’ve declining oxygen ranges, shortness of breath and any unexplained swelling, Parikh suggested.
“When you have been beforehand recognized with deep vein thrombosis or have persistent medical sickness that predisposes you to blood clots, you might have the next danger for recurrence of a deep vein thrombus within the setting of a COVID-19 an infection and thus, ought to be vigilant,” Parikh stated.
The American Society of Hematology has extra on blood clots.
SOURCE: Rutgers College, information launch, Might 15, 2021